From the magazine

Tofacitinib: cardiovascular and cancer risks

Janus kinase inhibitors are oral targeted agents used for the treatment of various chronic inflammatory diseases including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and atopic dermatitis.
Attention to details: An update on ADHD treatment
Problem solved: How do I get patients to take virtual appointments as seriously as in-person appointments?

Four docs gave us their best advice!
Innovators: Taking speciality care to new levels

He owns four pharmacies and has launched multiple speciality health services, yet Jason Cridge still finds time to mentor the next generation of pharmacy innovators.
Gout: Spotlight on urate-lowering therapy

Gout is the most common form of inflammatory arthritis, is caused by monosodium urate crystal deposition in joints.
The biggest threat to FPs is FPs

Let’s spitball about FPs and fulfillment . . .
Family doctors’ out-of-office passions

A baker, a sommelier and an astronaut candidate—all in one Canadian city.
Sink or swim

A man felt dizzy while swimming and then started to drown. Was it a seizure or was something else happening?

Stroke risk with antidopaminergic antiemetics